COVID-19 Impact on Osteoarthritis Pain Solution Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Osteoarthritis Pain Solution, including the following market information:
Major competitors identified in this market include Pfizer, Johnson and Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma, etc.
Based on the Region:
- Global Osteoarthritis Pain Solution Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Osteoarthritis Pain Solution Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Osteoarthritis Pain Solution Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Osteoarthritis Pain Solution Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Pfizer, Johnson and Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Oral
- Injection
- External
- Medical Care
- Personal Care
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Osteoarthritis Pain Solution Industry
1.7 COVID-19 Impact: Osteoarthritis Pain Solution Market Trends
2 GLOBAL OSTEOARTHRITIS PAIN SOLUTION QUARTERLY MARKET SIZE ANALYSIS
2.1 Osteoarthritis Pain Solution Business Impact Assessment - COVID-19
2.1.1 Global Osteoarthritis Pain Solution Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Osteoarthritis Pain Solution Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Osteoarthritis Pain Solution Quarterly Market Size, 2019 VS 2020
3.2 By Players, Osteoarthritis Pain Solution Headquarters and Area Served
3.3 Date of Key Players Enter into Osteoarthritis Pain Solution Market
3.4 Key Players Osteoarthritis Pain Solution Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON OSTEOARTHRITIS PAIN SOLUTION SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Oral
1.4.2 Injection
1.4.3 External
4.2 By Type, Global Osteoarthritis Pain Solution Market Size, 2019-2021
5 IMPACT OF COVID-19 ON OSTEOARTHRITIS PAIN SOLUTION SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Medical Care
5.5.2 Personal Care
5.2 By Application, Global Osteoarthritis Pain Solution Market Size, 2019-2021
5.2.1 By Application, Global Osteoarthritis Pain Solution Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Business Overview
7.1.2 Pfizer Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.1.3 Pfizer Osteoarthritis Pain Solution Product Introduction
7.1.4 Pfizer Response to COVID-19 and Related Developments
7.2 Johnson and Johnson
7.2.1 Johnson and Johnson Business Overview
7.2.2 Johnson and Johnson Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.2.3 Johnson and Johnson Osteoarthritis Pain Solution Product Introduction
7.2.4 Johnson and Johnson Response to COVID-19 and Related Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Business Overview
7.3.2 GlaxoSmithKline Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.3.3 GlaxoSmithKline Osteoarthritis Pain Solution Product Introduction
7.3.4 GlaxoSmithKline Response to COVID-19 and Related Developments
7.4 Bayer
7.4.1 Bayer Business Overview
7.4.2 Bayer Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.4.3 Bayer Osteoarthritis Pain Solution Product Introduction
7.4.4 Bayer Response to COVID-19 and Related Developments
7.5 Eli Lilly
7.5.1 Eli Lilly Business Overview
7.5.2 Eli Lilly Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.5.3 Eli Lilly Osteoarthritis Pain Solution Product Introduction
7.5.4 Eli Lilly Response to COVID-19 and Related Developments
7.6 Novartis
7.6.1 Novartis Business Overview
7.6.2 Novartis Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.6.3 Novartis Osteoarthritis Pain Solution Product Introduction
7.6.4 Novartis Response to COVID-19 and Related Developments
7.7 Sanofi
7.7.1 Sanofi Business Overview
7.7.2 Sanofi Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.7.3 Sanofi Osteoarthritis Pain Solution Product Introduction
7.7.4 Sanofi Response to COVID-19 and Related Developments
7.8 Horizon Pharma
7.8.1 Horizon Pharma Business Overview
7.8.2 Horizon Pharma Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.8.3 Horizon Pharma Osteoarthritis Pain Solution Product Introduction
7.8.4 Horizon Pharma Response to COVID-19 and Related Developments
7.9 Abbott
7.9.1 Abbott Business Overview
7.9.2 Abbott Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.9.3 Abbott Osteoarthritis Pain Solution Product Introduction
7.9.4 Abbott Response to COVID-19 and Related Developments
7.10 Mylan
7.10.1 Mylan Business Overview
7.10.2 Mylan Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.10.3 Mylan Osteoarthritis Pain Solution Product Introduction
7.10.4 Mylan Response to COVID-19 and Related Developments
7.11 Daiichi Sankyo
7.11.1 Daiichi Sankyo Business Overview
7.11.2 Daiichi Sankyo Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.11.3 Daiichi Sankyo Osteoarthritis Pain Solution Product Introduction
7.11.4 Daiichi Sankyo Response to COVID-19 and Related Developments
7.12 TEVA
7.12.1 TEVA Business Overview
7.12.2 TEVA Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.12.3 TEVA Osteoarthritis Pain Solution Product Introduction
7.12.4 TEVA Response to COVID-19 and Related Developments
7.13 Almatica Pharma
7.13.1 Almatica Pharma Business Overview
7.13.2 Almatica Pharma Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.13.3 Almatica Pharma Osteoarthritis Pain Solution Product Introduction
7.13.4 Almatica Pharma Response to COVID-19 and Related Developments
7.14 Astellas Pharma
7.14.1 Astellas Pharma Business Overview
7.14.2 Astellas Pharma Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.14.3 Astellas Pharma Osteoarthritis Pain Solution Product Introduction
7.14.4 Astellas Pharma Response to COVID-19 and Related Developments
7.15 Tide Pharmaceutical
7.15.1 Tide Pharmaceutical Business Overview
7.15.2 Tide Pharmaceutical Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.15.3 Tide Pharmaceutical Osteoarthritis Pain Solution Product Introduction
7.15.4 Tide Pharmaceutical Response to COVID-19 and Related Developments
7.16 Iroko Pharmaceuticals
7.16.1 Iroko Pharmaceuticals Business Overview
7.16.2 Iroko Pharmaceuticals Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.16.3 Iroko Pharmaceuticals Osteoarthritis Pain Solution Product Introduction
7.16.4 Iroko Pharmaceuticals Response to COVID-19 and Related Developments
7.17 Hengrui Pharmaceutical
7.17.1 Hengrui Pharmaceutical Business Overview
7.17.2 Hengrui Pharmaceutical Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.17.3 Hengrui Pharmaceutical Osteoarthritis Pain Solution Product Introduction
7.17.4 Hengrui Pharmaceutical Response to COVID-19 and Related Developments
7.18 Abiogen Pharma
7.18.1 Abiogen Pharma Business Overview
7.18.2 Abiogen Pharma Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.18.3 Abiogen Pharma Osteoarthritis Pain Solution Product Introduction
7.18.4 Abiogen Pharma Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Osteoarthritis Pain Solution Industry
1.7 COVID-19 Impact: Osteoarthritis Pain Solution Market Trends
2 GLOBAL OSTEOARTHRITIS PAIN SOLUTION QUARTERLY MARKET SIZE ANALYSIS
2.1 Osteoarthritis Pain Solution Business Impact Assessment - COVID-19
2.1.1 Global Osteoarthritis Pain Solution Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Osteoarthritis Pain Solution Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Osteoarthritis Pain Solution Quarterly Market Size, 2019 VS 2020
3.2 By Players, Osteoarthritis Pain Solution Headquarters and Area Served
3.3 Date of Key Players Enter into Osteoarthritis Pain Solution Market
3.4 Key Players Osteoarthritis Pain Solution Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON OSTEOARTHRITIS PAIN SOLUTION SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Oral
1.4.2 Injection
1.4.3 External
4.2 By Type, Global Osteoarthritis Pain Solution Market Size, 2019-2021
5 IMPACT OF COVID-19 ON OSTEOARTHRITIS PAIN SOLUTION SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Medical Care
5.5.2 Personal Care
5.2 By Application, Global Osteoarthritis Pain Solution Market Size, 2019-2021
5.2.1 By Application, Global Osteoarthritis Pain Solution Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Business Overview
7.1.2 Pfizer Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.1.3 Pfizer Osteoarthritis Pain Solution Product Introduction
7.1.4 Pfizer Response to COVID-19 and Related Developments
7.2 Johnson and Johnson
7.2.1 Johnson and Johnson Business Overview
7.2.2 Johnson and Johnson Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.2.3 Johnson and Johnson Osteoarthritis Pain Solution Product Introduction
7.2.4 Johnson and Johnson Response to COVID-19 and Related Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Business Overview
7.3.2 GlaxoSmithKline Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.3.3 GlaxoSmithKline Osteoarthritis Pain Solution Product Introduction
7.3.4 GlaxoSmithKline Response to COVID-19 and Related Developments
7.4 Bayer
7.4.1 Bayer Business Overview
7.4.2 Bayer Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.4.3 Bayer Osteoarthritis Pain Solution Product Introduction
7.4.4 Bayer Response to COVID-19 and Related Developments
7.5 Eli Lilly
7.5.1 Eli Lilly Business Overview
7.5.2 Eli Lilly Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.5.3 Eli Lilly Osteoarthritis Pain Solution Product Introduction
7.5.4 Eli Lilly Response to COVID-19 and Related Developments
7.6 Novartis
7.6.1 Novartis Business Overview
7.6.2 Novartis Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.6.3 Novartis Osteoarthritis Pain Solution Product Introduction
7.6.4 Novartis Response to COVID-19 and Related Developments
7.7 Sanofi
7.7.1 Sanofi Business Overview
7.7.2 Sanofi Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.7.3 Sanofi Osteoarthritis Pain Solution Product Introduction
7.7.4 Sanofi Response to COVID-19 and Related Developments
7.8 Horizon Pharma
7.8.1 Horizon Pharma Business Overview
7.8.2 Horizon Pharma Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.8.3 Horizon Pharma Osteoarthritis Pain Solution Product Introduction
7.8.4 Horizon Pharma Response to COVID-19 and Related Developments
7.9 Abbott
7.9.1 Abbott Business Overview
7.9.2 Abbott Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.9.3 Abbott Osteoarthritis Pain Solution Product Introduction
7.9.4 Abbott Response to COVID-19 and Related Developments
7.10 Mylan
7.10.1 Mylan Business Overview
7.10.2 Mylan Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.10.3 Mylan Osteoarthritis Pain Solution Product Introduction
7.10.4 Mylan Response to COVID-19 and Related Developments
7.11 Daiichi Sankyo
7.11.1 Daiichi Sankyo Business Overview
7.11.2 Daiichi Sankyo Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.11.3 Daiichi Sankyo Osteoarthritis Pain Solution Product Introduction
7.11.4 Daiichi Sankyo Response to COVID-19 and Related Developments
7.12 TEVA
7.12.1 TEVA Business Overview
7.12.2 TEVA Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.12.3 TEVA Osteoarthritis Pain Solution Product Introduction
7.12.4 TEVA Response to COVID-19 and Related Developments
7.13 Almatica Pharma
7.13.1 Almatica Pharma Business Overview
7.13.2 Almatica Pharma Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.13.3 Almatica Pharma Osteoarthritis Pain Solution Product Introduction
7.13.4 Almatica Pharma Response to COVID-19 and Related Developments
7.14 Astellas Pharma
7.14.1 Astellas Pharma Business Overview
7.14.2 Astellas Pharma Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.14.3 Astellas Pharma Osteoarthritis Pain Solution Product Introduction
7.14.4 Astellas Pharma Response to COVID-19 and Related Developments
7.15 Tide Pharmaceutical
7.15.1 Tide Pharmaceutical Business Overview
7.15.2 Tide Pharmaceutical Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.15.3 Tide Pharmaceutical Osteoarthritis Pain Solution Product Introduction
7.15.4 Tide Pharmaceutical Response to COVID-19 and Related Developments
7.16 Iroko Pharmaceuticals
7.16.1 Iroko Pharmaceuticals Business Overview
7.16.2 Iroko Pharmaceuticals Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.16.3 Iroko Pharmaceuticals Osteoarthritis Pain Solution Product Introduction
7.16.4 Iroko Pharmaceuticals Response to COVID-19 and Related Developments
7.17 Hengrui Pharmaceutical
7.17.1 Hengrui Pharmaceutical Business Overview
7.17.2 Hengrui Pharmaceutical Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.17.3 Hengrui Pharmaceutical Osteoarthritis Pain Solution Product Introduction
7.17.4 Hengrui Pharmaceutical Response to COVID-19 and Related Developments
7.18 Abiogen Pharma
7.18.1 Abiogen Pharma Business Overview
7.18.2 Abiogen Pharma Osteoarthritis Pain Solution Quarterly Revenue, 2020
7.18.3 Abiogen Pharma Osteoarthritis Pain Solution Product Introduction
7.18.4 Abiogen Pharma Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Osteoarthritis Pain Solution Assessment
Table 9. COVID-19 Impact: Osteoarthritis Pain Solution Market Trends
Table 10. COVID-19 Impact Global Osteoarthritis Pain Solution Market Size
Table 11. Global Osteoarthritis Pain Solution Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Osteoarthritis Pain Solution Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Osteoarthritis Pain Solution Market Growth Drivers
Table 14. Global Osteoarthritis Pain Solution Market Restraints
Table 15. Global Osteoarthritis Pain Solution Market Opportunities
Table 16. Global Osteoarthritis Pain Solution Market Challenges
Table 17. By Players, Osteoarthritis Pain Solution Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Osteoarthritis Pain Solution Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Osteoarthritis Pain Solution Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Osteoarthritis Pain Solution Market
Table 21. Key Players Osteoarthritis Pain Solution Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Osteoarthritis Pain Solution Market Size 2019-2021, (US$ Million)
Table 24. Global Osteoarthritis Pain Solution Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Osteoarthritis Pain Solution Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 57. Pfizer Business Overview
Table 58. Pfizer Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Pfizer Osteoarthritis Pain Solution Product
Table 60. Pfizer Response to COVID-19 and Related Developments
Table 61. Johnson and Johnson Business Overview
Table 62. Johnson and Johnson Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Johnson and Johnson Osteoarthritis Pain Solution Product
Table 64. Johnson and Johnson Response to COVID-19 and Related Developments
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. GlaxoSmithKline Osteoarthritis Pain Solution Product
Table 68. GlaxoSmithKline Response to COVID-19 and Related Developments
Table 69. Bayer Business Overview
Table 70. Bayer Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Bayer Osteoarthritis Pain Solution Product
Table 72. Bayer Response to COVID-19 and Related Developments
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Eli Lilly Osteoarthritis Pain Solution Product
Table 76. Eli Lilly Response to COVID-19 and Related Developments
Table 77. Novartis Business Overview
Table 78. Novartis Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Novartis Osteoarthritis Pain Solution Product
Table 80. Novartis Response to COVID-19 and Related Developments
Table 81. Sanofi Business Overview
Table 82. Sanofi Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Sanofi Osteoarthritis Pain Solution Product
Table 84. Sanofi Response to COVID-19 and Related Developments
Table 85. Horizon Pharma Business Overview
Table 86. Horizon Pharma Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Horizon Pharma Osteoarthritis Pain Solution Product
Table 88. Horizon Pharma Response to COVID-19 and Related Developments
Table 89. Abbott Business Overview
Table 90. Abbott Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Abbott Osteoarthritis Pain Solution Product
Table 92. Abbott Response to COVID-19 and Related Developments
Table 93. Mylan Business Overview
Table 94. Mylan Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Mylan Osteoarthritis Pain Solution Product
Table 96. Mylan Response to COVID-19 and Related Developments
Table 97. Daiichi Sankyo Business Overview
Table 98. Daiichi Sankyo Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Daiichi Sankyo Osteoarthritis Pain Solution Product
Table 100. Daiichi Sankyo Response to COVID-19 and Related Developments
Table 101. TEVA Business Overview
Table 102. TEVA Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. TEVA Osteoarthritis Pain Solution Product
Table 104. TEVA Response to COVID-19 and Related Developments
Table 105. Almatica Pharma Business Overview
Table 106. Almatica Pharma Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Almatica Pharma Osteoarthritis Pain Solution Product
Table 108. Almatica Pharma Response to COVID-19 and Related Developments
Table 109. Astellas Pharma Business Overview
Table 110. Astellas Pharma Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Astellas Pharma Osteoarthritis Pain Solution Product
Table 112. Astellas Pharma Response to COVID-19 and Related Developments
Table 113. Tide Pharmaceutical Business Overview
Table 114. Tide Pharmaceutical Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. Tide Pharmaceutical Osteoarthritis Pain Solution Product
Table 116. Tide Pharmaceutical Response to COVID-19 and Related Developments
Table 117. Iroko Pharmaceuticals Business Overview
Table 118. Iroko Pharmaceuticals Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. Iroko Pharmaceuticals Osteoarthritis Pain Solution Product
Table 120. Iroko Pharmaceuticals Response to COVID-19 and Related Developments
Table 121. Hengrui Pharmaceutical Business Overview
Table 122. Hengrui Pharmaceutical Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 123. Hengrui Pharmaceutical Osteoarthritis Pain Solution Product
Table 124. Hengrui Pharmaceutical Response to COVID-19 and Related Developments
Table 125. Abiogen Pharma Business Overview
Table 126. Abiogen Pharma Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 127. Abiogen Pharma Osteoarthritis Pain Solution Product
Table 128. Abiogen Pharma Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Osteoarthritis Pain Solution Assessment
Table 9. COVID-19 Impact: Osteoarthritis Pain Solution Market Trends
Table 10. COVID-19 Impact Global Osteoarthritis Pain Solution Market Size
Table 11. Global Osteoarthritis Pain Solution Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Osteoarthritis Pain Solution Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Osteoarthritis Pain Solution Market Growth Drivers
Table 14. Global Osteoarthritis Pain Solution Market Restraints
Table 15. Global Osteoarthritis Pain Solution Market Opportunities
Table 16. Global Osteoarthritis Pain Solution Market Challenges
Table 17. By Players, Osteoarthritis Pain Solution Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Osteoarthritis Pain Solution Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Osteoarthritis Pain Solution Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Osteoarthritis Pain Solution Market
Table 21. Key Players Osteoarthritis Pain Solution Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Osteoarthritis Pain Solution Market Size 2019-2021, (US$ Million)
Table 24. Global Osteoarthritis Pain Solution Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Osteoarthritis Pain Solution Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Osteoarthritis Pain Solution Market Size, 2019-2021 (US$ Million)
Table 57. Pfizer Business Overview
Table 58. Pfizer Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Pfizer Osteoarthritis Pain Solution Product
Table 60. Pfizer Response to COVID-19 and Related Developments
Table 61. Johnson and Johnson Business Overview
Table 62. Johnson and Johnson Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Johnson and Johnson Osteoarthritis Pain Solution Product
Table 64. Johnson and Johnson Response to COVID-19 and Related Developments
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. GlaxoSmithKline Osteoarthritis Pain Solution Product
Table 68. GlaxoSmithKline Response to COVID-19 and Related Developments
Table 69. Bayer Business Overview
Table 70. Bayer Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Bayer Osteoarthritis Pain Solution Product
Table 72. Bayer Response to COVID-19 and Related Developments
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Eli Lilly Osteoarthritis Pain Solution Product
Table 76. Eli Lilly Response to COVID-19 and Related Developments
Table 77. Novartis Business Overview
Table 78. Novartis Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Novartis Osteoarthritis Pain Solution Product
Table 80. Novartis Response to COVID-19 and Related Developments
Table 81. Sanofi Business Overview
Table 82. Sanofi Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Sanofi Osteoarthritis Pain Solution Product
Table 84. Sanofi Response to COVID-19 and Related Developments
Table 85. Horizon Pharma Business Overview
Table 86. Horizon Pharma Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Horizon Pharma Osteoarthritis Pain Solution Product
Table 88. Horizon Pharma Response to COVID-19 and Related Developments
Table 89. Abbott Business Overview
Table 90. Abbott Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Abbott Osteoarthritis Pain Solution Product
Table 92. Abbott Response to COVID-19 and Related Developments
Table 93. Mylan Business Overview
Table 94. Mylan Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Mylan Osteoarthritis Pain Solution Product
Table 96. Mylan Response to COVID-19 and Related Developments
Table 97. Daiichi Sankyo Business Overview
Table 98. Daiichi Sankyo Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Daiichi Sankyo Osteoarthritis Pain Solution Product
Table 100. Daiichi Sankyo Response to COVID-19 and Related Developments
Table 101. TEVA Business Overview
Table 102. TEVA Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. TEVA Osteoarthritis Pain Solution Product
Table 104. TEVA Response to COVID-19 and Related Developments
Table 105. Almatica Pharma Business Overview
Table 106. Almatica Pharma Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Almatica Pharma Osteoarthritis Pain Solution Product
Table 108. Almatica Pharma Response to COVID-19 and Related Developments
Table 109. Astellas Pharma Business Overview
Table 110. Astellas Pharma Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Astellas Pharma Osteoarthritis Pain Solution Product
Table 112. Astellas Pharma Response to COVID-19 and Related Developments
Table 113. Tide Pharmaceutical Business Overview
Table 114. Tide Pharmaceutical Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. Tide Pharmaceutical Osteoarthritis Pain Solution Product
Table 116. Tide Pharmaceutical Response to COVID-19 and Related Developments
Table 117. Iroko Pharmaceuticals Business Overview
Table 118. Iroko Pharmaceuticals Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. Iroko Pharmaceuticals Osteoarthritis Pain Solution Product
Table 120. Iroko Pharmaceuticals Response to COVID-19 and Related Developments
Table 121. Hengrui Pharmaceutical Business Overview
Table 122. Hengrui Pharmaceutical Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 123. Hengrui Pharmaceutical Osteoarthritis Pain Solution Product
Table 124. Hengrui Pharmaceutical Response to COVID-19 and Related Developments
Table 125. Abiogen Pharma Business Overview
Table 126. Abiogen Pharma Osteoarthritis Pain Solution Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 127. Abiogen Pharma Osteoarthritis Pain Solution Product
Table 128. Abiogen Pharma Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Osteoarthritis Pain Solution Product Picture
Figure 2. Osteoarthritis Pain Solution Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Osteoarthritis Pain Solution Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Osteoarthritis Pain Solution Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Osteoarthritis Pain Solution Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Osteoarthritis Pain Solution Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Osteoarthritis Pain Solution Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Osteoarthritis Pain Solution Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Osteoarthritis Pain Solution Market Size Market Share, 2019-2021
Figure 1. Osteoarthritis Pain Solution Product Picture
Figure 2. Osteoarthritis Pain Solution Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Osteoarthritis Pain Solution Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Osteoarthritis Pain Solution Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Osteoarthritis Pain Solution Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Osteoarthritis Pain Solution Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Osteoarthritis Pain Solution Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Osteoarthritis Pain Solution Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Osteoarthritis Pain Solution Market Size Market Share, 2019-2021
